Exchange: NASDAQ·Updated 07:30 PM EST
NGNE logo

NGNE Neurogene Inc

$22.15
$0.78
(3.40%)
Today
Closed $22.15
$0.00
(0.00%)
After Hours
Reported EarningsNov 9
Mkt Cap$458.53M
Vol178,268.00

About NGNE

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
54

Neutral Sentiment

How do you feel about NGNE?

Advertisement|Remove ads.